Immune Escape in Glioblastoma Multiforme and the Adaptation of Immunotherapies for Treatment

Glioblastoma multiforme (GBM) is the most frequently occurring primary brain tumor and has a very poor prognosis, with only around 5% of patients surviving for a period of 5 years or more after diagnosis. Despite aggressive multimodal therapy, consisting mostly of a combination of surgery, radiother...

Volledige beschrijving

Bewaard in:
Bibliografische gegevens
Gepubliceerd in:Front Immunol
Hoofdauteurs: Pearson, Joshua R. D., Cuzzubbo, Stefania, McArthur, Simon, Durrant, Lindy G., Adhikaree, Jason, Tinsley, Chris J., Pockley, A. Graham, McArdle, Stephanie E. B.
Formaat: Artigo
Taal:Inglês
Gepubliceerd in: Frontiers Media S.A. 2020
Onderwerpen:
Immunology
Online toegang:https://ncbi.nlm.nih.gov/pmc/articles/PMC7594513/
https://ncbi.nlm.nih.gov/pubmed/33178210
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.3389/fimmu.2020.582106
Tags: Voeg label toe
Geen labels, Wees de eerste die dit record labelt!

Gelijkaardige items